Limits Progression of Keratoconus

FDA Approved

Insurance Reimbursement

Avedro’s corneal cross-linking procedure is the first and only therapeutic treatment that stiffens the cornea to slow the progression of the keratoconus.

Learn about Insurance Coverage View Now

1

Minimally Invasive Procedure

2

KXL System for Treatment

What is Cross-Linking?

Corneal collagen cross-linking is the first and only FDA-approved therapeutic treatment for progressive keratoconus that combines the use of ultra-violet light and riboflavin eye drops.

Want to See the Difference? View Keratoconus Vision Simulator

Find a Cross-Linking Expert Near You Search Now

MA-00685D

Stay Connected

© 2021 Living with Keratoconus. Glaukos® is a registered trademark of Glaukos Corporation. iLink™ is a trademark of Glaukos Corporation. Photrexa®, Photrexa® Viscous, and the KXL® system are registered trademarks of Avedro, a Glaukos company. All Rights Reserved. Glaukos Corporation.

APPROVED USES
Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) are used with the KXL® System in corneal cross-linking to treat eyes in which the cornea, the clear dome shaped surface that covers the front of the eye, has been weakened from the progression of the disease keratoconus or following refractive surgery, a method for correcting or improving your vision.

Tell your healthcare provider if you are pregnant or plan to become pregnant.

IMPORTANT SAFETY INFORMATION
Ulcerative keratitis, a potentially serious eye infection, can occur. Your doctor should monitor defects in the outermost corneal layer of the eye for resolution.

The most common ocular side effect is haze. Other ocular side effects include inflammation, fine white lines, dry eye, disruption of surface cells, eye pain, light sensitivity, reduced sharpness of vision, and blurred vision. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider.

Go to Prescribing Info to obtain the FDA-approved product labeling.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Text Optimizer